静脉注射丙种球蛋白无反应型川崎病的预测:一个研究热点  

Prediction of intravenous immunoglobulin-resistant Kawasaki disease:a research hotspot

作　　者：徐泊雯 张清友 杜军保 Isao Shiraishi 金红芳 Bowen Xu;Qingyou Zhang;Junbao Du;Isao Shiraishi;Hongfang Jin(Department of Pediatrics,Peking University First Hospital,Beijing 100034,China;Key Laboratory of Cardiovascular Sciences,the Ministry of Education,Beijing 100191,China;Department of Pediatric Cardiology,National Cerebral and Cardiovascular Center,Osaka 564-8565,Japan)

机构地区：[1]Department of Pediatrics,Peking University First Hospital,Beijing 100034,China [2]Key Laboratory of Cardiovascular Sciences,the Ministry of Education,Beijing 100191,China [3]Department of Pediatric Cardiology,National Cerebral and Cardiovascular Center,Osaka 564-8565,Japan

出　　处：《Science Bulletin》2023年第2期121-124,M0003,共5页科学通报（英文版）

摘　　要：Kawasaki disease(KD) is an acute and self-limited febrile disease characterized by fever, polymorphic rash, bulbar conjunctival congestion, redness of the lip mucosa, unilateral cervical lymphadenopathy, erythema, and edema of the extremities. KD was reported first by Tomisaku Kawasaki, a Japanese scholar, in 1967[1]. Since then, the disease has been reported worldwide, with significant differences observed in its incidence in different regions.

关 键 词：KAWASAKI 无反应型川崎病 静脉注射丙种球蛋白 

分 类 号：R725.4[医药卫生—儿科]